|
Diabetes, Vol 42, Issue 12 1868-1877, Copyright © 1993 by American Diabetes Association
Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM
L Luzi, AS Petrides and RA De Fronzo
Department of Internal Medicine, University of Texas Health Science Center, San Antonio 78284.
NIDDM subjects are characterized by impaired glucose tolerance and insulin
resistance with respect to glucose metabolism. To examine whether the
defect in glucose utilization extends to amino acid metabolism, 6 NIDDM
subjects (64 +/- 4 yr of age; ideal body weight of 107 +/- 3%) and 7
control subjects (58 +/- 4 yr of age; ideal body weight of 105 +/- 2%) were
studied with the euglycemic insulin clamp technique, in combination with
[1-14C]leucine and indirect calorimetry. All subjects participated in two
studies. In study 1, after 3 h of tracer equilibration, a 3-h insulin clamp
(40 mU.m-2 x min-1) was performed to define the effect of insulin on
leucine kinetics and glucose metabolism. In study 2, subjects received a
repeat 3-h insulin clamp, and a balanced amino acid solution was infused to
increase the plasma amino acid concentrations approximately 2-fold to
examine the effect of combined physiological
hyperinsulinemia-hyperaminoacidemia on the rate of leucine and glucose
disposal. Insulin-mediated total body glucose uptake was significantly
reduced in NIDDM during both study 1 (5.6 +/- 0.4 vs. 6.9 +/- 0.6 mg.kg-1 x
min-1, P < 0.01) and study 2 (5.2 +/- 0.4 vs. 6.8 +/- 0.6, P < 0.01).
Basal plasma leucine (120 +/- 10 vs. 123 +/- 11 microM) and
alpha-ketoisocaproic acid concentrations (28 +/- 3 vs. 25 +/- 2 microM)
were similar in NIDDM and control subjects, respectively. In contrast, the
basal plasma glucose concentration (8.9 +/- 0.8 vs. 4.7 +/- 0.2 microM) and
the HbA1c (8.5 +/- 0.2 vs. 5.7 +/- 0.2%) were significantly increased in
NIDDM (P < 0.01). In the postabsorptive state, endogenous leucine flux,
leucine oxidation, and nonoxidative leucine disposal were similar in NIDDM
and control subjects. When insulin was infused without amino acids (study
1), the decrement in plasma leucine (53 +/- 5 vs. 48 +/- 4 microM),
endogenous leucine flux (13 +/- 2 vs. 11 +/- 1 mumol.m-2 x min-1), leucine
oxidation (1.6 +/- 0.2 vs. 1.3 +/- 0.1 mumol.m-2 x min-1), and nonoxidative
leucine disposal (10 +/- 1 vs. 8 +/- 1 mumol.m-2 x min-1) was comparable in
both groups. During combined insulin and amino acid infusion (study 2),
plasma leucine concentration (185 +/- 20 vs. 190 +/- 15 microM) rose
similarly in NIDDM and control subjects.(ABSTRACT TRUNCATED AT 400 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Moller and K. S. Nair
Diabetes and Protein Metabolism
Diabetes,
January 1, 2008;
57(1):
3 - 4.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pereira, E. B. Marliss, J. A. Morais, S. Chevalier, and R. Gougeon
Insulin Resistance of Protein Metabolism in Type 2 Diabetes
Diabetes,
January 1, 2008;
57(1):
56 - 63.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. C Maki, T. M Rains, V. N Kaden, K. R Raneri, and M. H Davidson
Effects of a reduced-glycemic-load diet on body weight, body composition, and cardiovascular disease risk markers in overweight and obese adults
Am. J. Clinical Nutrition,
March 1, 2007;
85(3):
724 - 734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Reeds, W. T. Cade, B. W. Patterson, W. G. Powderly, S. Klein, and K. E. Yarasheski
Whole-Body Proteolysis Rate Is Elevated in HIV-Associated Insulin Resistance.
Diabetes,
October 1, 2006;
55(10):
2849 - 2855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Bell, E. Volpi, S. Fujita, J. G. Cadenas, M. Sheffield-Moore, and B. B. Rasmussen
Skeletal Muscle Protein Anabolic Response to Increased Energy and Insulin Is Preserved in Poorly Controlled Type 2 Diabetes
J. Nutr.,
May 1, 2006;
136(5):
1249 - 1255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Tessari, A. Coracina, E. Kiwanuka, M. Vedovato, M. Vettore, A. Valerio, M. Zaramella, and G. Garibotto
Effects of Insulin on Methionine and Homocysteine Kinetics in Type 2 Diabetes With Nephropathy
Diabetes,
October 1, 2005;
54(10):
2968 - 2976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guillet, A. Zangarelli, P. Gachon, B. Morio, C. Giraudet, P. Rousset, and Y. Boirie
Whole Body Protein Breakdown Is Less Inhibited by Insulin, But Still Responsive to Amino Acid, in Nondiabetic Elderly Subjects
J. Clin. Endocrinol. Metab.,
December 1, 2004;
89(12):
6017 - 6024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lattuada, L. P. Sereni, D. Ruggieri, A. Scollo, S. Benedini, F. Ragogna, F. Costantino, A. Battezzati, L. Luzi, and G. Perseghin
Postabsorptive and Insulin-Stimulated Energy Homeostasis and Leucine Turnover in Offspring of Type 2 Diabetic Patients
Diabetes Care,
November 1, 2004;
27(11):
2716 - 2722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Barazzoni, E. Kiwanuka, M. Zanetti, M. Cristini, M. Vettore, and P. Tessari
Insulin Acutely Increases Fibrinogen Production in Individuals With Type 2 Diabetes but Not in Individuals Without Diabetes
Diabetes,
July 1, 2003;
52(7):
1851 - 1856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Halvatsiotis, K. R. Short, M. Bigelow, and K. S. Nair
Synthesis Rate of Muscle Proteins, Muscle Functions, and Amino Acid Kinetics in Type 2 Diabetes
Diabetes,
August 1, 2002;
51(8):
2395 - 2404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sreekumar, P. Halvatsiotis, J. C. Schimke, and K. S. Nair
Gene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment
Diabetes,
June 1, 2002;
51(6):
1913 - 1920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Richardson and J. A. Tayek
Type 2 diabetic patients may have a mild form of an injury response: a clinical research center study
Am J Physiol Endocrinol Metab,
June 1, 2002;
282(6):
E1286 - E1290.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Benedini, R. Fiocchi, A. Battezzati, P. Scifo, L. P. Sereni, A. Gamba, C. Mammana, A. Del Maschio, G. Perseghin, and L. Luzi
Energy Metabolism in Diabetic and Nondiabetic Heart Transplant Recipients
Diabetes Care,
March 1, 2002;
25(3):
530 - 536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Boirie, P. Gachon, N. Cordat, P. Ritz, and B. Beaufrère
Differential Insulin Sensitivities of Glucose, Amino Acid, and Albumin Metabolism in Elderly Men and Women
J. Clin. Endocrinol. Metab.,
February 1, 2001;
86(2):
638 - 644.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Luzi, G. Perseghin, M. D. Brendel, I. Terruzzi, A. Battezzati, M. Eckhard, D. Brandhorst, H. Brandhorst, S. Friemann, C. Socci, et al.
Metabolic Effects of Restoring Partial {beta}-Cell Function After Islet Allotransplantation in Type 1 Diabetic Patients
Diabetes,
February 1, 2001;
50(2):
277 - 282.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Schutz, C. M Rueda-Maza, M. Zaffanello, and C. Maffeis
Whole-body protein turnover and resting energy expenditure in obese, prepubertal children
Am. J. Clinical Nutrition,
May 1, 1999;
69(5):
857 - 862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. De Feo
Fed State Protein Metabolism in Diabetes Mellitus
J. Nutr.,
February 1, 1998;
128(2):
328 - 328.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Solini, E. Bonora, R. Bonadonna, P. Castellino, and R. A. DeFronzo
Protein Metabolism in Human Obesity: Relationship with Glucose and Lipid Metabolism and with Visceral Adipose Tissue
J. Clin. Endocrinol. Metab.,
August 1, 1997;
82(8):
2552 - 2558.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1993 by the American Diabetes Association.
|
|
| |
|